AIFM2 and cancer: Furthermore, FSP1 catalyzes the reduction of vitamin K (VK) to vitamin K hydroquinone (VKH2), a potent antioxidant that significantly enhances ferroptosis resistance by protecting cancer cells from iron-mediated oxidative damage [12,13,14].